Kite Pharma CEO steps down from Teva board
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Arie Belldegrun resigned from the Teva Pharmaceutical Industries Ltd. board to focus on his responsibilities at Kite Pharma Inc.
Belldegrun is the chairman, president, CEO and founder of Kite Pharma. He joined the Teva board in 2013.